T48.3X4
Poisoning by antitussives, undetermined
Clinical Classification Guidelines
Medical Intelligence & Overview
Poisoning by antitussives occurs when someone ingests or absorbs more of these cough suppressant medications than intended, leading to toxic effects. The ICD-10 code T48.3X4 specifically refers to cases where the cause is undetermined, meaning it's not clear whether the poisoning was accidental, intentional, or due to other factors. Antitussives are medications used to suppress coughs, often found in cold and cough remedies. While generally safe when used as directed, excessive or improper use can result in poisoning that requires medical attention.
Causes & Symptoms
Clinical Causes: Accidental overdose, especially in children or individuals taking multiple medications Intentional overdose in cases of self-harm or suicide attempts Misuse or abuse of antitussive medications for recreational purposes Unintentional ingestion of large quantities of cough syrup or combination products Incorrect dosing due to misunderstandings or lack of knowledge about medication instructions
Key Symptoms: Nausea and vomiting Dizziness and lightheadedness Drowsiness or excessive sleepiness Confusion or impaired consciousness Hallucinations or agitation in severe cases Respiratory depression or difficulty breathing Blurred vision or pupils that are unusually large or small Unusual tiredness or weakness Skin rash or allergic reactions (rare)
Diagnostic & Treatment
Diagnosis Path: Diagnosing poisoning by antitussives involves a review of the patient's medical history, careful physical examination, and laboratory tests. Blood tests can detect the presence and concentration of the medication, helping confirm overdose. Medical professionals may also assess the patient's neurological status, respiratory function, and other vital signs. Additional tests could include urine analysis and possible toxicology screening to identify other substances that might be involved.
Treatment Protocols: Managing poisoning by antitussives requires prompt medical intervention. Treatment strategies generally include supportive care aimed at stabilizing vital functions, such as maintaining airway, breathing, and circulation. Specific treatments may involve: - Activated charcoal administration to absorb the toxin if the ingestion was recent - Intravenous fluids to prevent dehydration and support kidney function - Medications to reverse sedation or manage seizures, if applicable - Monitoring and managing respiratory depression with oxygen therapy or mechanical ventilation in severe cases - Continuous observation until the medication clears from the patient's system In some situations, healthcare providers might use medications like naloxone if opioid components are involved, although antitussives are usually non-opioid. In cases of severe poisoning, hospitalization in an intensive care setting may be necessary to ensure patient safety and recovery.
Clinical Advice & FAQs
Billing Guidance
Is T48.3X4 a billable ICD-10 code?
Yes, T48.3X4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T48.3X4?
Clinical documentation must specify the nature of Poisoning by antitussives, undetermined and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
